Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tmanke
    Member
    • Oct 2009
    • 26

    #1

    PhD opportunity (Bioinformatics, Neuroscience, Epigenetics)

    The Max Planck Institute of Immunobiology and Epigenetics and the University of Freiburg, Germany offers a PhD position in the group of Thomas Manke. The position is available for a three-year appointment.

    Your tasks:
    You will be part of a newly established research training group (MeInBio), which aims at a dual education in bioinformatics and wet laboratory methods to explore the spatiotemporal dynamics of gene regulation using high-throughput and high-resolution methods. This specific project aims at understanding the genome organization during neuronal differentiation at high resolution. To this end, detailed molecular maps of histone modifications, chromatin states and chromatin conformation in 3D will be generated, analyzed and interpreted.

    Your qualifications:
    PhD applicants should hold a MSc/Diploma in life sciences, ideally with a strong computational component. MSc in Bioinformatics or Informatics will be considered, if they can demonstrate practical expertise with molecular biology techniques. We are looking for highly motivated candidates who are showing strong interest in interdisciplinary research and the desire to work at the interface of epigenetics, neuroscience and bioinformatics. We also expect fluency in both written and spoken English.

    We offer:
    - Dual education in computational and molecular biology
    - State-of-the-art technologies and infrastructure (e.g. deep-sequencing, imaging, bioinformatics)
    - International, multidisciplinary environment
    - Regular courses in bioinformatics, laboratory techniques and soft skills
    - Great location at the heart of the Black Forest and in close vicinity to France and Switzerland
    Salary will be based on the MPG Support of Junior Scientists guidelines.

    Application deadline:
    Have we sparked your interest? Please submit your complete application, including a statement of research interests, a CV and contact details for at least two referees via our online application portal at www.ie-freiburg.mpg.de until November 24th, 2017.

    Direct link: http://www.ie-freiburg.mpg.de/488224...68621?c=722066

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 07:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...